| 2008 | Echogenic carotid artery plaques are associated with vertebral fractures in postmenopausal women with low bone mass. | CALCIFIED TISSUE INTERNATIONAL |
| 2009 | Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone | DIABETIC MEDICINE |
| 2014 | Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without caridiovascular event | ENDOCRINE |
| 1997 | Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone | INTERNATIONAL JOURNAL OF OBESITY |
| 2011 | Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
| EUROPEAN JOURNAL OF ENDOCRINOLOGY |
| 2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
| 2022 | Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice
| BIOMEDICINES |
| 2018 | Effects of Combination Therapy of Statin and Thiazolidinedione on Vascular Inflammation
| KOREAN CIRCULATION JOURNAL |
| 2006 | Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control | CLINICAL ENDOCRINOLOGY |
| 2006 | Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2018 | Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice | INTERNATIONAL JOURNAL OF OBESITY |
| 2016 | Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
| PLOS ONE |
| 2010 | Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients.
| NEPHROLOGY DIALYSIS TRANSPLANTATION |
| 2005 | Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes | CLINICAL PHARMACOLOGY & THERAPEUTICS |
| 2007 | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus | CLINICAL ENDOCRINOLOGY |
| 2008 | Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2018 | Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
| Endocrinology and Metabolism (대한내분비학회지) |
| 2019 | Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial | DIABETES OBESITY & METABOLISM |
| 2019 | Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus | TRANSPLANTATION PROCEEDINGS |
| 2018 | Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
| DIABETES OBESITY & METABOLISM |
| 2020 | Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks | DIABETES OBESITY & METABOLISM |
| 2016 | Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
| MEDICINE |
| 2016 | Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial
| JOURNAL OF DIABETES INVESTIGATION |
| 2018 | Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
| 2012 | Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance.
| CARDIOVASCULAR DIABETOLOGY |
| 2016 | Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK | INTERNATIONAL JOURNAL OF OBESITY |
| 2017 | Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition | AUTOPHAGY |
| 2022 | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
| BMC MEDICINE |
| 2016 | Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis | FREE RADICAL BIOLOGY AND MEDICINE |
| 2011 | Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
| 2002 | Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonists | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES |
| 2006 | Frequent, Aggressive Behaviors of Thyroid Microcarcinomas in Korean Patients
| ENDOCRINE JOURNAL |
| 2020 | Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes
| SCIENTIFIC REPORTS |
| 2013 | Gastrectomy for Early Gastric Cancer is Associated with Decreased Cardiovascular Mortality in Association with Postsurgical Metabolic Changes | ANNALS OF SURGICAL ONCOLOGY |
| 2019 | Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria | Journal of Diabetes and Its Complications |
| 2015 | Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetes
| CARDIOVASCULAR DIABETOLOGY |
| 2013 | Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy Dysfunction | ENDOCRINOLOGY |
| 2011 | Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients | ACTA DIABETOLOGICA |
| 2015 | Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1c with Time
| BIOMED RESEARCH INTERNATIONAL |
| 2013 | Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
| DIABETES & METABOLISM JOURNAL |
| 2012 | Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus.
| DIABETES & METABOLISM JOURNAL |
| 2004 | Graves' Disease Associated with Klinefelter's Syndrome
| YONSEI MEDICAL JOURNAL |
| 2006 | Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2020 | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
| MEDICINE |
| 2005 | High Prevalence of c-RET Expression in Papillary Thyroid Carcinomas from the Korean Population | THYROID |
| 2014 | High prevalence of spine-femur bone mineral density discordance and comparison of vertebral fracture risk assessment using femoral neck and lumbar spine bone density in Korean patients | JOURNAL OF BONE AND MINERAL METABOLISM |
| 2012 | Higher morning to evening ratio in total dose of twice-daily biphasic insulin analog might be effective in achieving glucose control in patients with poorly controlled type 2 diabetes. | DIABETES TECHNOLOGY & THERAPEUTICS |
| 2014 | HMG CoA Reductase Inhibitor Treatment Induces Dysglycemia in Renal Allograft Recipients | TRANSPLANTATION |
| 2000 | Homeostasis Model Assessment법을 이용한 인술린저항성 평가의 한계 | Journal of Korean Diabetes Association (당뇨병) |
| 2005 | Hypercalcemia in hepatic tuberculosis: A case report in Korea
| AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE |
| 2008 | Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients.
| ENDOCRINE JOURNAL |
| 2000 | Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus | Diabetes Research and Clinical Practice |
| 2017 | Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia
| MEDICINE |
| 2005 | Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARγ agonists
| AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM |
| 2023 | Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2022 | Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
| Endocrinology and Metabolism(대한내분비학회지) |
| 2017 | Increase in resting heart rate over 2 years predicts incidence of diabetes: A 10-year prospective study | DIABETES & METABOLISM |
| 2015 | Increased expression of ATP-binding cassette transporter A1 (ABCA1) as a possible mechanism for the protective effect of cilostazol against hepatic steatosis | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2023 | Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis | METABOLISM-CLINICAL AND EXPERIMENTAL |
